Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,931
datasets available to search
ShareScore release 0.9.0
Dataset results
6,931 results for “Obesity.”
Data from: Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals
Background: Interactions between the diet and intestinal microbiota play a role in health and disease, including obesity and related metabolic complications. There is great interest to use dietary means to manipulate the microbiota to promote health. Currently, the impact of dietary change on the microbiota and the host metabolism is poorly predictable and highly individual. We propose that the responsiveness of the gut microbiota may depend on its composition, and associate with metabolic changes in the host. Methodology: Our study involved three independent cohorts of obese adults (n = 78) from Belgium, Finland, and Britain, participating in different dietary interventions aiming to improve metabolic health. We used a phylogenetic microarray for comprehensive fecal microbiota analysis at baseline and after the intervention. Blood cholesterol, insulin and inflammation markers were analyzed as indicators of host response. The data were divided into four training set – test set pairs; each intervention acted both as a part of a training set and as an independent test set. We used linear models to predict the responsiveness of the microbiota and the host, and logistic regression to predict responder vs. non-responder status, or increase vs. decrease of the health parameters. Principal Findings: Our models, based on the abundance of several, mainly Firmicute species at baseline, predicted the responsiveness of the microbiota (AUC = 0.77–1; predicted vs. observed correlation = 0.67–0.88). Many of the predictive taxa showed a non-linear relationship with the responsiveness. The microbiota response associated with the change in serum cholesterol levels with an AUC of 0.96, highlighting the involvement of the intestinal microbiota in metabolic health. Conclusion: This proof-of-principle study introduces the first potential microbial biomarkers for dietary responsiveness in obese individuals with impaired metabolic health, and reveals the potential of microbiota signatures for personalized nutrition.
Data from: Obesity-induced decreases in muscle performance are not reversed by weight loss
BACKGROUND/OBJECTIVES: Obesity can affect muscle phenotypes, and may thereby constrain movement and energy expenditure. Weight loss is a common and intuitive intervention for obesity, but it is not known whether the effects of obesity on muscle function are reversible by weight loss. Here we tested whether obesity-induced changes in muscle metabolic and contractile phenotypes are reversible by weight loss. SUBJECTS/METHODS: We used zebrafish (Danio rerio) in a factorial design to compare energy metabolism, locomotor capacity, muscle isometric force and work-loop power output, and myosin heavy chain (MHC) composition between lean fish, diet-induced obese fish, and fish that were obese and then returned to lean body mass following diet restriction. RESULTS: Obesity increased resting metabolic rates (Po0.001) and decreased maximal metabolic rates (P = 0.030), but these changes were reversible by weight loss, and were not associated with changes in muscle citrate synthase activity. In contrast, obesity-induced decreases in locomotor performance (P = 0.0034), and isolated muscle isometric stress (P = 0.01), work-loop power output (Po0.001) and relaxation rates (P = 0.012) were not reversed by weight loss. Similarly, obesity-induced decreases in concentrations of fast and slow MHCs, and a shift toward fast MHCs were not reversed by weight loss. CONCLUSION: Obesity-induced changes in locomotor performance and muscle contractile function were not reversible by weight loss. These results show that weight loss alone may not be a sufficient intervention.
Data from: Postoperative changes in fecal bacterial communities and fermentation products in obese patients undergoing bilio-intestinal bypass
We assessed the gut microbial ecology of 11 severely obese patients before and after bilio-intestinal bypass (BIB). Fecal samples were evaluated for microbial communities using 16S rDNA Illumina sequencing, real-time PCR targeting functional genes, and gas chromatography of short chain fatty acids (SCFAs). At 6 months after surgery, subjects exhibited significant improvements in metabolic markers (body weight, glucose, and lipid metabolism) compared with baseline. The fecal microbiota of post-surgery individuals was characterized by an overall decrease of bacterial diversity, with a significant reduction in Lachnospiraceae, Clostridiaceae, Ruminococcaceae, Eubacteriaceae, and Coriobacteriaceae. On the contrary, there were significant increases of genera Lactobacillus, Megasphaera, and Acidaminococcus and the family Enterobacteriaceae. The pH was decreased in fecal samples from patients after BIB and SCFA profiles were altered, with lower percentages of acetate and propionate and higher levels of valerate and hexanoate. Some changes in the bacterial populations were associated with variations in the patients' metabolic health parameters, namely Gemmiger and glucose, Lactobacillus and glucose, and Faecalibacterium and triglycerides. The results from this study of BIB patients furthers our understanding of the composition of gut microbiota and the functional changes that may be involved in improving obesity-related conditions following weight-loss surgery.
Data from: Ophthalmologic evaluation of severely obese patients undergoing bariatric surgery: a pilot, monocentric, prospective, open-label study
Purpose: The aim of this study was to investigate the pathogenic role of obesity on blinding eye diseases in a population of severely obese patients with no history of eye diseases, and to verify whether weight loss induced by bariatric surgery may have a protective effect. Methods: This was a pilot, monocentric, prospective, and open label study conducted at the University Hospital of Pisa. Fifty-seven severely obese patients with a mean body mass index value of 44.1 ± 6 kg/m2 were consecutively recruited and received a complete ophthalmological evaluation and optical coherence tomography. Twenty-nine patients who underwent gastric bypass were evaluated also 3 months, and 1 year after surgery. Results: At baseline, blood pressure value were directly and significantly related to intraocular pressure values (p<0.05, R = 0.35). Blood pressure values were also significantly and inversely related to retinal nerve fiber layer thickness, particularly in the temporal sector (RE p<0.05 r-0.30; LE p<0.01, R = -0.43). Moreover, minimum foveal thickness values were significantly and inversely associated with body mass index (RE p<0.02, R = -0.40; LE p<0.02, R = -0.30). A significant reduction of body mass index (p<0.05) and a significant (p<0.05) improvement of blood pressure was observed three months and one year after gastric bypass, which were significantly associated with an increase in retinal nerve fiber layer thickness and minimum foveal thickness values in both eyes (p<0.05). Conclusions: The results of this study suggest that obese patients may have a greater susceptibility to develop glaucomatous optic nerve head damage and age-related macular degeneration. Moreover, weight reduction and improvement of comorbidities obtained by bariatric surgery may be effective in preventing eye disease development by improving retinal nerve fiber layer and foveal thickness.
The Relationship between Obesity-Related Factors and Graves' Orbitopathy
<p><b><i>Background/Objectives</i></b><i>:</i> The aim of this study was to investigate whether there are relationships between obesity-related factors including body mass index (BMI), diabetes or prediabetes, hyperlipidemia, fasting plasma glucose, fasting plasma insulin, homeostasis model assessment-estimated insulin resistance (HOMA-IR), and high sensitive C-reactive protein (hs-CRP) and Graves' orbitopathy (GO).</p> <p><b><i>Subjects/Methods</i></b>: Eighty-four patients with Graves' disease (GD) (42 without GO and 42 with GO) were enrolled in this Cross-sectional cohort study. Sex, age, GD treatment history, height, body weight, waist circumference, smoking status, co-morbidities, and levels of free thyroxin, thyroid-stimulating hormone, thyroid-stimulating hormone receptor (TSHR) antibodies, fasting plasma glucose and insulin, and hs-CRP were recorded. Eye condition was evaluated using the NOSPECS classification and clinical activity score.</p> <p><b><i>Results</i></b>: BMI, fasting plasma insulin, and HOMA-IR were associated with the presence of GO after adjusting for age, sex, smoking, TSHR antibodies, and steroid usage (adjusted odd's ratio〔OR〕1.182, 95% confidence interval (95% CI), 1.003-1.393, <i>p</i>=0.046; adjusted OR 1.165, 95% CI, 1.001-1.355, <i>p</i>=0.048; and adjusted OR 1.985, 95% CI, 1.046-3.764, <i>p</i>=0.036, respectively). In addition, BMI, fasting plasma glucose, fasting plasma insulin, HOMA-IR, and hs-CRP levels were positively correlated with the severity of GO (Spearman's rho=0.285, <i>p</i>=0.009; Spearman's rho=0.298, <i>p</i>=0.006; Spearman's rho=0.243, <i>p</i>=0.026; Spearman's rho=0.270, <i>p</i>=0.013; and Spearman's rho=0.299,<i> p</i>=0.006, respectively).</p> <p><b><i>Conclusion</i></b>: The findings of this study suggest that obesity and obesity-related factors, and especially fasting plasma insulin and HOMA-IR are related to GO.</p>
Linking socioeconomic inequalities and type 2 diabetes through obesity and lifestyle factors among Mexican adults: a structural equations modeling approach
<p><strong>Objective. </strong>To assess the association between type 2 diabetes (DM2) and socioeconomic inequalities, mediated by the contribution of body mass index (BMI), physical activity (PA), and diet (diet-DII). <strong>Materials and methods</strong>. We conducted a cross-sectional analysis using data of adults participating in the Diabetes Mellitus Survey of Mexico City. Socioeconomic and demographic characteristics as well as height and weight, dietary intake, leisure time activity and the presence of DM2 were measured. We fitted a structural equation model (SEM) with DM2 as the main outcome, and BMI, diet-DII and PA served as mediator variables between socioeconomic inequalities index (SII) and DM2. <strong>Results. </strong>The prevalence of DM2 was 13.6%. From the fitted SEM, each standard deviation increases in the SII was associated with increased scores of DM2 (β=0.174, <em>P</em><0.001). <strong>Conclusion. </strong>The results in the present study show how high scores in the index of SII may influence the presence of DM2.</p>
Data from: Reproductive and behavior dysfunction induced by maternal androgen exposure and obesity is likely not gut microbiome-mediated
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder of unclear etiology in women and is characterized by androgen excess, insulin resistance, and mood disorders. The gut microbiome is known to influence conditions closely related with PCOS, and several recent studies have observed changes in the stool microbiome of women with PCOS. The mechanism by which the gut microbiome interacts with PCOS is still unknown. We used a mouse model to investigate if diet-induced maternal obesity and maternal dihydrotestosterone (DHT) exposure, mimicking the lean and obese PCOS women, cause lasting changes in the gut microbiome of offspring. Fecal microbiome profiles were assessed using Illumina paired-end sequencing of 16S rRNA gene V4 amplicons. We found sex-specific effects of maternal and offspring diet, and maternal DHT exposure on fecal bacterial richness and taxonomic composition. Female offspring exposed to maternal obesity and DHT displayed reproductive dysfunction and anxiety-like behavior. Fecal microbiota transplantation from DHT and diet-induced obesity exposed female offspring to wild-type mice did not transfer reproductive dysfunction and did not cause the expected increase in anxiety-like behavior in recipients. Maternal obesity and androgen exposure affect the gut microbiome of offspring, but the disrupted estrous cycles and anxiety-like behavior are likely not microbiome-mediated.
Obesity and the Receipt of Influenza and Pneumococcal Vaccination: a Systematic Review and Meta-analysis dataset
<p>Meta-analysis dataset from <strong>Obesity and the Receipt of Influenza and Pneumococcal Vaccination: a Systematic Review and Meta-analysis</strong>, in press at BMC Obesity</p>
Microevolution Hypothesis of the Obesity Epidemic Dataset
<p>Includes all data used in study titled: "The Microevolutionary Hypothesis of the Obesity Epidemic" including National obesity rates, Maternal Death Rates, Maternal Morality, GDP, calorie intake, physical inactivity, antibiotic use</p>
The impact of cognitive distraction on gustatory perception in volunteers with obesity
Open the record for dataset details and reuse information.
DOES OBESITY DRIVE THE DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME? AN EPIDEMIOLOGIC STUDY (SUPPLEMENTARY TABLES)
<p>These are the Supplementary tables for manuscript entitled 'Does Obesity Drive the Development of Polycystic Ovary Syndrome? An Epidemiologic Study', denoting: Table 1: the search strategy for the systematic review; Table 2: the NOS quality scoring of included studies; and Table 3: the association between mean BMI or obesity prevalence and PCOS prevalence by PCOS diagnostic criteria. </p>
Principal component analysis as an efficient method for capturing multivariate brain signatures of complex disorders-ENIGMA study in people with bipolar disorders and obesity
<p>Multivariate techniques better fit the anatomy of complex neuropsychiatric disorders which are characterized not by alterations in a single region, but rather by variations across distributed brain networks. Here, we used principal component analysis (PCA) to identify patterns of covariance across brain regions and relate them to clinical and demographic variables in a large generalizable dataset of individuals with bipolar disorders and controls. We then compared performance of PCA and clustering on identical sample to identify which methodology was better in capturing links between brain and clinical measures. Using data from the ENIGMA-BD working group, we investigated T1-weighted structural MRI data from 2436 participants with BD and healthy controls, and applied PCA to cortical thickness and surface area measures. We then studied the association of principal components with clinical and demographic variables using mixed regression models. We compared the PCA model with our prior clustering analyses of the same data and also tested it in a replication sample of 327 participants with BD or schizophrenia and healthy controls. The first principal component, which indexed a greater cortical thickness across all 68 cortical regions, was negatively associated with BD, BMI, antipsychotic medications, and age and was positively associated with Li treatment. PCA demonstrated superior goodness of fit to clustering when predicting diagnosis and BMI. Moreover, applying the PCA model to the replication sample yielded significant differences in cortical thickness between healthy controls and individuals with BD or schizophrenia. Cortical thickness in the same widespread regional network as determined by PCA was negatively associated with different clinical and demographic variables, including diagnosis, age, BMI, and treatment with antipsychotic medications or lithium. PCA outperformed clustering and provided an easy-to-use and interpret method to study multivariate associations between brain structure and system-level variables. </p>
Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity
<p>The present study aimed to identify <em>ADCY3</em> genetic variants in severely obese young patients of Greek-Cypriot origin by genomic sequencing. Total genomic DNA samples were isolated from peripheral whole blood using the Gentra Puregene Blood kit (Qiagen GmbH). DNA sequencing was performed with 100 ng genomic DNA, which was amplified using primers designed by Primer3 software ver. 0.4.0 (http://frodo.wi.mit.edu/). PCR mixtures were prepared using the Taq DNA Polymerase Kit (Qiagen GmbH); they had a final volume of 20 μl and contained 2 μl PCR buffer (10X), 2 μl Q Solution (5X), 2 μl dNTPs (2mM), 0.3 μl of each primer (10μM), 0.2 μl Taq polymerase (5U/μl) and 100 ng genomic DNA. Amplification was performed with an initial denaturing temperature at 95˚C for 5 min, followed by 30 cycles of denaturation (95˚C, 45 sec), annealing (57˚C, 60 sec) and extension (72˚C, 45 sec), with a final extension at 72˚C for 5 min. The <em>ADCY3</em> gene primers covered all exons. The PCR products were analysed on an Applied Biosystems 3130xl Genetic Analyzer and the results were analysed using Sequencing Analysis R 5.3 software (Applied Biosystems; Thermo Fisher Scientific, Inc.). The results revealed a total of five variants in patients, four of which were previously reported. A novel variant was identified in two patients (6%). The novel variant involves a heterozygous c.349T>A change in exon 1 of the gene locus, leading to a missense p.Leu117Met substitution.</p>
A low molecular weight Saccharina japonica polysaccharide suppresses high fat diet-induced obesity and enriches gut bacteria with fucoidan-degrading potential
<p>This dataset contains 16S rRNA gene and metagenomic sequencing raw data involved in this study. Metagenomic data (S21H1887, S21H1888) were obtained from two cecal content samples from the LFD_J2H group due to<em> Akkermansia</em> uncultured bacterium was highly abundant in these samples. In addition, the code for JS divergence analysis is included.</p>
Dataset of the study "Factor Structure, Validity, and Reliability of the STarT Back Screening Tool in Italian Obese and Non-obese Patients With Low Back Pain"
<p>Dataset of the study "Factor Structure, Validity, and Reliability of the STarT Back Screening Tool in Italian Obese and Non-obese Patients With Low Back Pain" published in Frontiers in Psychology 20 October 2021 12:740851, doi: 10.3389/fpsyg.2021.740851</p>
Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life
<p>Obesity is a pre-disposing condition for chronic obstructive pulmonary disease, asthma, and pulmonary arterial hypertension. Accumulating evidence suggests that metabolic influences during development can determine chronic lung diseases (CLD). We demonstrate that maternal obesity causes early metabolic disorder in the offspring. Here, interleukin-6 induced bronchial and microvascular smooth muscle cell (SMC) hyperproliferation and increased airway and pulmonary vascular resistance. The key anti-proliferative transcription factor FoxO1 was inactivated via nuclear exclusion. These findings were confirmed using primary SMC treated with interleukin-6 and pharmacological FoxO1 inhibition as well as genetic FoxO1 ablation and constitutive activation. In vivo, we reproduced the structural and functional alterations in offspring of obese dams via the SMC-specific ablation of FoxO1. The reconstitution of FoxO1 using IL-6-deficient mice and pharmacological treatment did not protect against metabolic disorder but prevented SMC hyperproliferation. In human observational studies, childhood obesity was associated with reduced forced expiratory volume in 1s/forced vital capacity ratio Z-score (used as proxy for lung function) and asthma. We conclude that the interleukin-6-FoxO1 pathway in SMC is a molecular mechanism by which perinatal obesity programs the bronchial and vascular structures and functions, thereby driving CLD development. Thus, FoxO1 reconstitution provides a potential therapeutic option for preventing this metabolic programming of CLD.</p>
Supplemental table 1. Results of systematic literature search for human studies of obesity-related hypothalamic inflammation and gliosis
<p>Supplemental table 1 for the manuscript entitled " The significance of hypothalamic inflammation and gliosis for the pathogenesis of obesity in humans".</p> <p> </p>
The effect of dietary supplementation with blueberry, cyanidin-3-O-β-glucoside, yoghurt and its peptides on gene expression associated with glucose metabolism in skeletal muscle obtained from a high-fat-high-carbohydrate diet induced obesity model
<p><span>Obesity is a leading global health problem contributing to various chronic diseases, including type II diabetes mellitus</span> <span>(T2DM). The aim of this study was to investigate whether blueberries, yoghurt, and their respective bioactive components, Cyanidin-3-O-β-glucoside (C3G) and peptides alone or in combinations, alter the expression of genes related to glucose metabolism in skeletal muscles from diet-induced obese mice. In extensor digitorum longus (EDL), yoghurt up-regulated the expression of activation of 5'adenosine monophosphate-activated protein kinase (AMPK), insulin receptor substrate-1 (IRS-1), phosphatidylinositol-3 kinase (PI3K) and glucose transporter 4 (GLUT4), and down-regulated the expression of angiotensin II receptor type 1 (AGTR-1). The combination of blueberries and yoghurt down-regulated the mRNA expression of AGTR-1 and Forkhead box protein O1 (FoxO1) in the EDL. Whereas the combination of C3G and peptides down-regulated AGTR-1 and up-regulated GLUT4 mRNA expression in the EDL. In the soleus, blueberries and yoghurt alone, and their combination down-regulated AGTR-1 and up-regulated GLUT4 mRNA expression. In summary blueberries and yoghurt, regulated multiple genes associated with glucose metabolism in skeletal muscles, and therefore may play a role in the management and prevention of T2DM.</span></p>
PRISMA Flowchart for the systematic review: Impact on postoperative complications of combined prehabilitation targeting co-exisiting smoking, malnutrition, obesity, alcohol drinking, and physical inactivity: a systematic review and meta-analysis of randomised trials
<p><strong><span>PRISMA 2020 Flow Chart.</span></strong><span> “No predefined risk factors” covers studies with relevant multimodal interventions that were excluded due to lack of predefined risky lifestyles in the population. “Only trial registration or conference abstract” covers reports of these but with no subsequent publication. SNAP: Smoking, Nutrition (overweight/obesity, malnutrition), Alcohol or Physical inactivity.</span></p>
Assessment of Airway Resistance and Specic Airway Conductance in Centrally Obese Adults
<p>Background:Obesity's systemic consequences impact pulmonary function, with central obesity exerting a more signicant inuence on pulmonary mechanics than peripheral obesity. Waist circumference (WC) emerges as a crucial parameter, yet research focusing on its specic impact on airway mechanics is limited. Objectives:The study aims to assess whether centrally obese adults exhibit distinct airway resistance and specic airway conductance compared to gender and age-matched controls using cross-sectional study. Methods:Atotal of ninety individuals between the ages of 20 and 40 took part in the study. The research group consisted of forty-ve individuals who were selected based on their waist circumference (WC) being equal to or more than 90 cm in males and 80 cm in women. The remaining 45 individuals were allocated to the control group according to their waist circumference(WC)beingbelow90cminmenand80cminfemales.Abody plethysmograph was used to assess airway resistance and conductance. The statistical methodology employed was appropriate, utilizing the Independent Student's t-test to compare the groups. Results:The ndings showed that the group that participated in the research had a higher airway resistance (P= 0.03) than the control group. No signicant disparity in specic airway conductance was observed between the two groups, following the application of suitable statistical tests for mean comparison (P= 0.99). Conclusion:Centrally obese adults experience increased airway resistance attributable to diminished lung volumes rather than intrinsic airway obstruction. This heightened respiratory effort underscores the importance of maintaining a normal waist circumference to mitigate potential respiratory challenges associated with central obesity</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.